www.亚洲精品,国产午夜片无码区在线播放,亚洲色婷婷综合开心网,日日干日日

技術(shù)文章您的位置:網(wǎng)站首頁(yè) >技術(shù)文章 > Invigentech轉(zhuǎn)染試劑高效率轉(zhuǎn)染DNA siRNA到免疫T細(xì)胞
Invigentech轉(zhuǎn)染試劑高效率轉(zhuǎn)染DNA siRNA到免疫T細(xì)胞
更新時(shí)間:2020-05-11   點(diǎn)擊次數(shù):1988次

一、浙江大學(xué)附屬第二醫(yī)院乳腺外科;浙江大學(xué)附屬第二醫(yī)院浙江省療法腫瘤微環(huán)境與免疫重點(diǎn)實(shí)驗(yàn)室;浙江省人民醫(yī)院,浙江省人民醫(yī)院,杭州醫(yī)學(xué)院附屬人民醫(yī)院,浙江省個(gè)體化醫(yī)學(xué)腫瘤分子診斷與診斷重點(diǎn)實(shí)驗(yàn)室;紹興大學(xué)附屬醫(yī)院甲狀腺乳腺外科在2020-2-19聯(lián)合發(fā)表標(biāo)題為Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells(乳腺癌衍生的外泌體傳遞lncRNA SNHG16誘導(dǎo)CD73 +γδ1 Treg細(xì)胞)的文章到nature /sigtrans,文章已被接受;

二、本研究使用中使用Invigentech(英克)公司INVI DNA RNA 轉(zhuǎn)染試劑轉(zhuǎn)染質(zhì)粒DNA、siRNA到Vδ1 T 免疫T細(xì)胞里面;

三、本文中轉(zhuǎn)染質(zhì)粒DNA、siRNA,轉(zhuǎn)染細(xì)胞數(shù)量信息如下:

A. 將全長(zhǎng)2435 bp的序列克隆到pCR3.1載體中構(gòu)建SNHG16過表達(dá)載體;

B. siRNA序列:SNHG16-homo-349,5′GCCUCUGCUGCUAAUUGUUTT-3'; SNHG16-homo-867, 5′-CCAAGGAGGGACUGUUUAATT-3′和SNHG16-homo-2004,5′-CCCAGUGUUGACUCACCAATT-3;

C. 轉(zhuǎn)染細(xì)胞用量:6孔板里面1 × 106 cells/well;

四、發(fā)表文章部分內(nèi)容如下:

Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells

Plasmid construction and siRNA silencing A full-length 2435 bp sequence was cloned into the pCR3.1 vector to

construct the SNHG16 overexpression vector. The sequences of SNHG16-specifific siRNAs were as follows: SNHG16-homo-349, 5′GCCUCUGCUGCUAAUUGUUTT-3′; SNHG16-homo-867, 5′-CCAAGGAGGGACUGUUUAATT-3′ and SNHG16-homo-2004, 5′-CCCAGUGUUGACUCACCAATT-3′. The miR-16–5p mimics, inhibitor and negative

controls were purchased from GenePharma (SupplementaryTable S3).

To manipulate the expression of miR-16–5p in Vδ1 T cells, Vδ1T cells were sorted from peripheral blood and seeded into six-wellplates at 1 × 106 cells/well with 1 ml of medium supplementedwith 10% FBS, 10 μg/ml CD3, 10 μg/ml CD28 and 40 U/mL IL-2.Then, transfection reagent (INVI DNA RNA Transfection Reagent,Invigentech, USA) and miR-16–5p mimics/NC/inhibitor/inhibitor NC (20 μm) were incubated with the cells for 48 h, after which the cells were collected for further experiments.

but not Vδ2+ T cells were revealed to comprise the majority of TILs in all three BC molecular subtypes when gated on CD3 (p < 0.01, Fig. 1b, c). In addition, immunoflfluorescence of frozen sections further confifirmed the dominant distribution of Vδ1+T cells in BC (Fig. 1d). 

To further identify the function of breast cancer-infifiltrating γδ1T cells, BC cell lines (MCF-7, T-47D, MDA-MB-231 and MDA-MB-468) were co-cultured with freshly isolated Vδ1+ T cells frombreast tumour tissue (E:T ratios: 1:1, 5:1 and 10:1). Upon plotting the cell growth curve, the data show that γδ1 T cells did not exert

 

invigentech(英克)INVI DNA RNA轉(zhuǎn)染試劑信息如下

產(chǎn)品名稱

貨號(hào)

規(guī)格

報(bào)價(jià)

INVI DNA RNA 轉(zhuǎn)染試劑

IV1216025

0.25 ml

詢價(jià)

INVI DNA RNA 轉(zhuǎn)染試劑

IV1216050

0.50 ml

詢價(jià)

INVI DNA RNA 轉(zhuǎn)染試劑

IV1216075

0.75 ml

詢價(jià)

INVI DNA RNA 轉(zhuǎn)染試劑

IV1216100

1.00 ml

詢價(jià)

INVI DNA RNA 轉(zhuǎn)染試劑

IV1216150

1.50 ml

詢價(jià)

INVI DNA RNA 轉(zhuǎn)染試劑

IV1216300

3.00 ml

詢價(jià)

©2024  上海創(chuàng)凌生物科技有限公司 All Rights Reserved.  網(wǎng)站地圖  滬ICP備2023009255號(hào)-1  管理登陸  技術(shù)支持:化工儀器網(wǎng)
在線客服 二維碼

掃一掃,關(guān)注我們